NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-039-2012-2-EP-06 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) EP National Stage 12795973.2 Issued
NCI E-039-2012-2-GB-07 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) GB EP 12795973.2 Issued
NIDA E-221-2010-0-US-03 Phenylmorpholines And Analogues Thereof US ORD 13/698,892 9617229 Issued PDF
NCI E-039-2012-2-JP-04 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) JP National Stage 2014-542565 Issued
NCI E-039-2012-2-PCT-01 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) PCT PCT PCT/US2012/065945 Expired
NCI E-038-2012-2-PCT-01 Therapeutic RNA Switches Compositions and Methods of Use PCT PCT PCT/US2012/065932 Expired
NCI E-038-2012-2-EP-04 Therapeutic RNA Switches Compositions and Methods of Use EP National Stage 12795971.6 Abandoned
NCI E-038-2012-2-JP-05 Therapeutic RNA Switches Compositions and Methods of Use JP National Stage 2014-542562 Abandoned
NCI E-038-2012-2-CA-03 Therapeutic RNA Switches Compositions and Methods of Use CA National Stage 2856116 Abandoned
NCI E-039-2012-2-CA-03 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) CA National Stage 2856117 Pending
NCI E-039-2012-2-AU-02 Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP) AU National Stage 2012340094 Abandoned
NCI E-038-2012-2-AU-02 Therapeutic RNA Switches Compositions and Methods of Use AU National Stage 2012340086 Abandoned
NCATS E-134-2010-0-US-07 Inhibitors of Human 12-Lipoxygenase US National Stage 13/698,340 Abandoned
NCI E-255-2011-0-PCT-02 A METHOD FOR POSTIVELY OR NEGATIVELY REGULATING THE ASSEMBLY OF NEWLY SYNTHESIZED CENP-A TO EXOGENOUS ALPHOID DNA CONTAINING CENP-B BOXES IN MAMMALIAN CELL LINES PCT PCT PCT/JP12/007384 Expired
NCATS E-148-2012-0-US-01 Tocopherol Analogues As Correctors Of Lysosomal Storage Disorders US 61/727,296 Abandoned
NCI E-201-2012-0-US-01 Methods of Treating Patients Infected With HIV and HTLV US 61/726,975 Abandoned
NHGRI E-007-1999-2-US-09 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers US CON 13/676,382 9284610 Expired PDF
NIDCR E-032-2013-0-PCT-02 METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS PCT PCT PCT/US2012/064909 Expired
NIAID E-241-2011-1-US-01 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES US CIP 13/675,447 Abandoned
NHLBI E-011-2010-0-US-04 Compositions And Methods For Preventing Or Treating A Human Parvovirus Infection US National Stage 13/578,577 Abandoned
NIAID E-241-2011-0-EP-02 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES EP ORD 12790771.5 Pending
NCI E-221-2012-0-US-01 Synallele Libraries US 61/725,807 Abandoned
NIAAA E-282-2012-0-US-01 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US 61/725,949 Abandoned
NIAID E-241-2011-1-PCT-02 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES PCT PCT COMB PCT/US12/064788 Expired
NIDCD E-222-2003-1-US-07 Variants Of Human Taste Receptor Genes US DIV 13/674,637 9783590 Issued PDF
NHLBI E-248-2011-0-PCT-02 Methods for Detecting Infectious Agents and A Novel Virus Detected Thereby PCT PCT PCT/US2012/064668 Expired
NCI E-013-2012-0-PCT-02 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY PCT PCT PCT/US2012/064693 Expired
NIAID E-014-2013-0-US-01 NOVEL ASSAY FOR CELLS EXPRESSING INFLUENZA VIRUS-SPECIFIC ANTIBODIES US 61/725,884 Abandoned
NCI E-013-2012-0-CA-03 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY CA National Stage 2854665 Abandoned
NIAID E-281-2011-0-PCT-02 Synthetic Catalase/Superoxide Dismutase Mimetics For Viral Infections PCT PCT PCT/US2012/064383 Expired
NIAID E-061-2012-0-PCT-02 Assay For Diabetes-Associated Autoantibodies PCT PCT PCT/US12/064373 Expired
NIAAA E-061-2010-0-HK-08 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE HK National Stage 12111349.1 Pending
NIAID E-253-2011-3-IN-04 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE IN National Stage 3678/DELNP/2014 Issued
NIAID E-253-2011-3-BR-07 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE BR National Stage BR112014010823-4 Issued
NIAID E-253-2011-3-GB-12 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE GB EP 12847241.2 Issued
NIAID E-253-2011-3-EP-03 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE EP National Stage 12847241.2 Issued
NIAID E-253-2011-3-DE-10 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE DE EP 12847241.2 Issued
NIAID E-253-2011-3-FR-11 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE FR EP 12847241.2 Issued
NIAID E-253-2011-3-ZA-06 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE ZA National Stage 2014/03264 Issued
NIAID E-253-2011-3-RU-08 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE RU National Stage 2014118462 Issued
NIAID E-253-2011-3-CN-02 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE CN National Stage 201280065580.1 Issued
NEI E-115-2010-0-US-10 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice US National Stage 13/581,884 Abandoned
NIAID E-253-2011-3-PCT-01 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE PCT PCT COMB PCT/US2012/063958 Expired
NHLBI E-003-2013-0-US-01 Methods For Treating Or Preventing Necrosis US 61/723,496 Abandoned
NIDDK E-064-2004-0-US-26 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT US CON 13/669,324 Abandoned
NCATS E-234-2012-0-TW-29 PAK Inhibitors For the Treatment of Fragile X Syndrome TW National Stage 101141080 Abandoned
NCATS E-234-2012-0-AR-31 PAK Inhibitors For the Treatment of Fragile X Syndrome AR National Stage 20120104155 Pending
NIAAA E-258-2012-0-US-01 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation US 61/722,630 Abandoned
NCATS E-234-2012-0-PCT-03 PAK Inhibitors For the Treatment of Fragile X Syndrome PCT PCT PCT/US12/063426 Expired
NCATS E-234-2012-0-CN-08 PAK Inhibitors For the Treatment of Fragile X Syndrome CN National Stage 201280066130.4 Pending